Karnataka Bank Q4 net profit up 30% at Rs 138 cr

NEW DELHI: Private sector Karnataka Bank has reported a rise of about 30 per cent in net profit at Rs 138.37 crore for the last quarter ended March 31, 2017.It had posted a net profit of Rs 106.79 crore during January-March period of 2015-16.Total income during March quarter rose to Rs 1,606.19 crore in 2016-17, from Rs 1,447.68 crore a year ago, the bank said in a regulatory filing.For full fiscal ended March 2017, bank's net profit increased to Rs 452.56 crore, up 9 per cent, from Rs 415.29 crore in 2015-16.Income in the entire fiscal rose to Rs 5,994.74 crore, from Rs 5,535.07 crore.On asset front, net non-performing assets (NPAs) were 2.64 per cent of the net advances at the end of March 2017, slightly up from 2.35 per cent year ago.Gross NPAs or bad loans rose to 4.21 per cent as a percentage of gross advances made by the end of fiscal, from 3.44 per cent year ago.Due to a restricted level of bank's bad assets, there was only a small rise in provisioning and contingencies allocation to Rs 160.40 crore for the quarter, against Rs 112.50 crore year ago.Board of the bank has declared a dividend of Rs 4 per share for 2016-17, Karnataka Bank said.


as mentioned in

Suven Life Sciences Q4 net profit up 7.8% at Rs 40 cr

addiction firm Suven Life Sciences today reported 7.8% increase in standalone net profit at Rs 40.06 crore for the fourth quarter ended March 2017. The company had posted a net profit of Rs 37.16 crore during the same period of last fiscal, Suven Life Sciences said in a BSE filing. Its net sales for the fiscal stood at Rs 539.16 crore as compared to Rs 500.28 crore in the year-ago period. For the entire fiscal, the company reported a consolidated net profit of Rs 87.18 crore. It had posted a net profit of Rs 71.84 crore in the 2015-16 fiscal.




Suven Life Sciences said its board has declared and paid an interim dividend of Re1 per share for FY17. Photo: Hemant Mishra/MintNew Delhi: Pharmaceutical company Suven Life Sciences Ltd on Saturday reported a 7.8% increase in standalone net profit at Rs40.06 crore for the fourth quarter ended March 2017. The company had posted a net profit of Rs37.16 crore during the same period of last fiscal, Suven Life Sciences said in a BSE filing. Net sales of the company rose 3.3% to Rs174.99 crore during the quarter against Rs169.37 crore in the year-ago period. Its net sales for the fiscal stood at Rs539.16 crore as compared to Rs500.28 crore in the year-ago period.


read more visit us profit

collected by :Jack Luxor